FDA approves Amgen drug for small cell lung cancer
Related Articles
-
FDA recalls faulty iOS app that injured hundreds of insulin pump users
The US Food and Drug Administration has issued a Class 1 recall for an iOS app that interfaces with an insulin pump due to a software glitch causing the app to crash and automatically restart. This intermittent malfunction drains the pump's battery and may lead to premature shutdown. Such aRead Entire Article
-
t:connect iOS app for insulin pump could kill users, says FDA
Version 2.7 of the t:connect iOS app – which is used to control delivery of insulin by the t:slim X2 pump – has been urgently recalled by the FDA. The FDA issued a Class I recall, which is reserved for products likely to cause “serious adverse health consequences or death” more
-
Disney+ to launch its first-ever interactive Original story as a Vision Pro app
Marvel announced that the first Disney+ Original interactive story will arrive for the Vision Pro. The immersive experience will soon be available for Apple's headset as a standalone app.